Zitieren

Abboud EC, Legare TB, Settle JC, et al. Do silver-based wound dressings reduce pain? A prospective study and review of the literature. Burns. 2014;40(suppl 1): S40–S47. AbboudEC LegareTB SettleJC Do silver-based wound dressings reduce pain? A prospective study and review of the literature Burns 2014 40 suppl 1 S40 S47 Search in Google Scholar

Benbow M. Best practice in wound assessment. Nurs Stand. 2016;30(27):40–47. BenbowM Best practice in wound assessment Nurs Stand 2016 30 27 40 47 Search in Google Scholar

Lo SF, Hayter M, Hu WY, Tai CY, Hsu MY, Li YF. Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs. 2012;68(6):1312–1321. LoSF HayterM HuWY TaiCY HsuMY LiYF Symptom burden and quality of life in patients with malignant fungating wounds J Adv Nurs 2012 68 6 1312 1321 Search in Google Scholar

Adderley U.J., Holt I.G. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014;(5):CD003948. AdderleyU.J. HoltI.G. Topical agents and dressings for fungating wounds Cochrane Database Syst Rev. 2014 5 CD003948 Search in Google Scholar

Alexander S. Malignant fungating wounds: key symptoms and psychosocial issues. J Wound Care. 2009;18: 325–329. AlexanderS Malignant fungating wounds: key symptoms and psychosocial issues J Wound Care 2009 18 325 329 Search in Google Scholar

Fromantin I, Watson S, Baffie A, et al. A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. Ostomy Wound Manage. 2014;60(6):38–48. FromantinI WatsonS BaffieA A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer Ostomy Wound Manage 2014 60 6 38 48 Search in Google Scholar

Samala RV, Davis MP. Comprehensive wound malodor management: win the RACE. Cleve Clin J Med. 2015;82(8):535–543. SamalaRV DavisMP Comprehensive wound malodor management: win the RACE Cleve Clin J Med 2015 82 8 535 543 Search in Google Scholar

Langemo DK, Anderson J, Hanson D, Hunter S, Thompson P. Managing fungating wounds. Adv Skin Wound Care. 2007;20(6):312–314. LangemoDK AndersonJ HansonD HunterS ThompsonP Managing fungating wounds Adv Skin Wound Care 2007 20 6 312 314 Search in Google Scholar

Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs. 2009;13(4):295–298. ProbstS ArberA FaithfullS Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland Eur J Oncol Nurs 2009 13 4 295 298 Search in Google Scholar

Thomas S, Fisher B, Fram PJ, Waring MJ. Odour-absorbing dressings. J Wound Care. 1998;7(5):246–250. ThomasS FisherB FramPJ WaringMJ Odour-absorbing dressings J Wound Care 1998 7 5 246 250 Search in Google Scholar

Ramasubbu DA, Smith V, Hayden F, Cronin P. Systemic antibiotics for treating malignant wounds. Cochrane Database Syst Rev. 2017;8:CD011609. RamasubbuDA SmithV HaydenF CroninP Systemic antibiotics for treating malignant wounds Cochrane Database Syst Rev 2017 8 CD011609 Search in Google Scholar

Samala RV, Davis MP. Comprehensive wound malodor management: win the RACE. Cleve Clin J Med. 2015;82(8):535–543. SamalaRV DavisMP Comprehensive wound malodor management: win the RACE Cleve Clin J Med 2015 82 8 535 543 Search in Google Scholar

Bower M, Stein R, Evans TR, Hedley A, Pert P, Coombes RC. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. Eur J Cancer. 1992;28a(4–5):888–889. BowerM SteinR EvansTR HedleyA PertP CoombesRC A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours Eur J Cancer 1992 28a 4–5 888 889 Search in Google Scholar

Watanabe K, Shimo A, Tsugawa K, et al. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013). Support Care Cancer. 2016;24(6):2583–2590. WatanabeK ShimoA TsugawaK Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013) Support Care Cancer 2016 24 6 2583 2590 Search in Google Scholar

Kuge S, Tokuda Y, Ohta M, et al. Use of metronidazole gel to control malodor in advanced and recurrent breast cancer. Jpn J Clin Oncol. 1996;26(4):207–210. KugeS TokudaY OhtaM Use of metronidazole gel to control malodor in advanced and recurrent breast cancer Jpn J Clin Oncol 1996 26 4 207 210 Search in Google Scholar

Adderley UJ, Holt IG. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014(5):CD003948. AdderleyUJ HoltIG Topical agents and dressings for fungating wounds Cochrane Database Syst Rev 2014 5 CD003948 Search in Google Scholar

Akhmetova A, Saliev T, Allan IU, Illsley MJ, Nurgozhin T, Mikhalovsky S. A comprehensive review of topical odor-controlling treatment options for chronic wounds. J Wound Ostomy Continence Nurs. 2016;43(6):598–609. AkhmetovaA SalievT AllanIU IllsleyMJ NurgozhinT MikhalovskyS A comprehensive review of topical odor-controlling treatment options for chronic wounds J Wound Ostomy Continence Nurs 2016 43 6 598 609 Search in Google Scholar

Coombs TJ. Product profile: more than a wound dressing. Health Soc Serv J. 1981;91(4768):1268–1269. CoombsTJ Product profile: more than a wound dressing Health Soc Serv J 1981 91 4768 1268 1269 Search in Google Scholar

Graham C. The role of silver in wound healing. Br J Nurs. 2005;14(19): S22, S24, S26. GrahamC The role of silver in wound healing Br J Nurs 2005 14 19 S22, S24, S26. Search in Google Scholar

Kalemikerakis J, Vardaki Z, Fouka G, et al. Comparison of foam dressings with silver versus foam dressings without silver in the care of malodorous malignant fungating wounds. J Buon. 2012;17(3):560–564. KalemikerakisJ VardakiZ FoukaG Comparison of foam dressings with silver versus foam dressings without silver in the care of malodorous malignant fungating wounds J Buon 2012 17 3 560 564 Search in Google Scholar

eISSN:
1792-362X
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Allgemeinmedizin, Innere Medizin, Hämatologie, Onkologie